Lie‐Feng Ma
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Biotechnology top 5%
- Marine Sponges and Natural Products
Papers in
-
- Natural product bioactivities and synthesis 11
- Pharmacology 17
- Microbial Natural Products and Biosynthesis 12
- Fungal Biology and Applications 9
- Co-authors
- Zha‐Jun Zhan (55 shared papers)Wei‐Guang Shan (28 shared papers)You‐Min Ying (17 shared papers)Yili Chen (3 shared papers)Xia Zhang (1 shared paper)Haibo Bai (1 shared paper)Linyan Zhang (1 shared paper)Rui Wu (3 shared papers)
- Journals
- Chemistry & Biodiversity (7 papers)Phytochemistry Letters (6 papers)Phytochemistry (5 papers)Helvetica Chimica Acta (4 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaNew ZealandCzechia
In The Last Decade
Lie‐Feng Ma
55 papers receiving 689 citations
Peers
Comparison fields: 5 of 64
- Pharmacology 218
- Biotechnology 106
- Pharmacology 92
- Cancer Research 142
- Biochemistry 59
Countries citing papers authored by Lie‐Feng Ma
This map shows the geographic impact of Lie‐Feng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lie‐Feng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lie‐Feng Ma more than expected).
Fields of papers citing papers by Lie‐Feng Ma
This network shows the impact of papers produced by Lie‐Feng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lie‐Feng Ma. The network helps show where Lie‐Feng Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Lie‐Feng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 148 | |
| 2 | 2014 | 69 | |
| 3 | 2020 | 56 | |
| 4 | 2020 | 28 | |
| 5 | 2011 | 24 | |
| 6 | 2015 | 23 | |
| 7 | 2016 | 21 | |
| 8 | 2018 | 18 | |
| 9 | 2015 | 17 | |
| 10 | 2020 | 15 | |
| 11 | 2024 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2008 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2024 | 12 | |
| 17 | 2018 | 12 | |
| 18 | 2024 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2014 | 10 |
About Lie‐Feng Ma
Lie‐Feng Ma is a scholar working on Molecular Biology, Pharmacology, Plant Science, Pharmacology and Cancer Research, having authored 57 papers that have together received 690 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (12 papers), Natural product bioactivities and synthesis (11 papers), Phytochemistry and Biological Activities (10 papers), Fungal Biology and Applications (9 papers), Phytochemistry and Bioactive Compounds (8 papers), Sesquiterpenes and Asteraceae Studies (7 papers), Marine Sponges and Natural Products (7 papers) and Traditional and Medicinal Uses of Annonaceae (6 papers). The work is most often cited by research in Pharmacology (218 citations), Biotechnology (106 citations), Pharmacology (92 citations), Cancer Research (142 citations) and Biochemistry (59 citations). Lie‐Feng Ma has collaborated with scholars based in China, New Zealand and Czechia. Frequent co-authors include Zha‐Jun Zhan, Wei‐Guang Shan, You‐Min Ying, Yili Chen, Xia Zhang, Haibo Bai, Linyan Zhang, Rui Wu, Yili Chen and Jianwei Wang. Their work appears in journals such as Chemistry & Biodiversity, Phytochemistry Letters, Phytochemistry, Helvetica Chimica Acta and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.